← Back to Search

Watermelon for High Blood Pressure (WMBP Trial)

N/A
Recruiting
Led By Indika Edirisinghe, Ph.D.
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Fasting blood glucose concentration between 100 mg/dL and 125 mg/dL at screening visit (value range indicate prediabetes, by finger prick and/or venous blood sampling)
Have no clinical evidence/history of cardiovascular, metabolic, respiratory, renal, gastrointestinal, or hepatic disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 4 weeks
Awards & highlights

WMBP Trial Summary

This trial studies how watermelon can help regulate blood pressure in people with pre-hypertension and its effects on other health factors.

Who is the study for?
This trial is for healthy overweight/obese adults aged 25-65 with slightly elevated blood pressure but no history of serious health issues. Participants should be nonsmokers, not on a vegetarian diet, and have stable weight without plans to lose more. They shouldn't consume certain supplements or medications that affect blood pressure or metabolism.Check my eligibility
What is being tested?
The study tests how different amounts of watermelon flesh impact blood pressure in people with pre-hypertension. It also looks at the effects on heart-related risk factors like cholesterol and metabolic markers. Participants will receive one of two doses of watermelon flesh or a control treatment.See study design
What are the potential side effects?
Since the intervention involves consuming watermelon, side effects are expected to be minimal but may include food-related allergies or intolerances for those sensitive to ingredients in the study's diet.

WMBP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My fasting blood sugar is between 100 and 125 mg/dL, indicating prediabetes.
Select...
I have no history of major organ or metabolic diseases.

WMBP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate the change in the dose response effects of watermelon flesh in regulating BP in individuals with pre-hypertension.
Secondary outcome measures
To evaluate the change in glucose in individuals with pre-hypertension after consuming watermelon flesh.
To evaluate the change in insulin in individuals with pre-hypertension after consuming watermelon flesh.
To evaluate the change in lipid profile in individuals with pre-hypertension after consuming watermelon flesh.
+2 more

WMBP Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Watermelon flesh Dose 1Active Control1 Intervention
1 cup watermelon flesh, ~152 g
Group II: Watermelon flesh Dose 2Active Control1 Intervention
2 cups watermelon flesh, ~304 g
Group III: ControlPlacebo Group1 Intervention
Calorie-matched control beverage

Find a Location

Who is running the clinical trial?

Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
53 Previous Clinical Trials
2,884 Total Patients Enrolled
National Watermelon Promotion BoardOTHER
1 Previous Clinical Trials
23 Total Patients Enrolled
Indika Edirisinghe, Ph.D.Principal InvestigatorIllinois Institute of Technology

Media Library

Watermelon Flesh Clinical Trial Eligibility Overview. Trial Name: NCT05892328 — N/A
Cardiovascular Disease Research Study Groups: Control, Watermelon flesh Dose 1, Watermelon flesh Dose 2
Cardiovascular Disease Clinical Trial 2023: Watermelon Flesh Highlights & Side Effects. Trial Name: NCT05892328 — N/A
Watermelon Flesh 2023 Treatment Timeline for Medical Study. Trial Name: NCT05892328 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies as an eligible participant for this research?

"Those with cardiovascular disease aged between 25 and 65 years old have the opportunity to join this trial. A total of 36 patients are invited participate in the study."

Answered by AI

Does this clinical experiment accept volunteers at present?

"Correct. Clinicaltrials.gov records show that this medical trial, which was first listed on April 7th 2023, is presently recruiting patients. Approximately 36 subjects are needed from one location."

Answered by AI

Does this experiment accept participants over 60 years of age?

"This clinical trial is looking for patients aged between 25 and 65."

Answered by AI

What is the aggregate size of participants enrolled in this experiment?

"Affirmative. The clinical trial listing on clinicaltrials.gov verifies that recruitment is currently underway for this study, which was initially posted on April 7th 2023 and subsequently updated on May 26th 2023. 36 participants are needed to be sourced from 1 medical clinic."

Answered by AI
~18 spots leftby Apr 2025